Home›Search›Endocrine, Metabolic and Immune Disorders - Drug Targets

Endocrine, Metabolic and Immune Disorders - Drug Targets

Bentham Science Publishers · United Arab Emirates · Est. 2006

ISSN2212-3873

SJR Q3✓ WOS SCIE✓ Scopus / SJR

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.552

H-Indexi

SNIPi

0.547

Total Worksi

2,039

Total Citationsi

26,414

2yr Mean Citednessi

1.30

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Endocrine, Metabolic & Immune Disorders - Drug Targets discusses Internal medicine, Diabetes mellitus, Endocrinology, Pharmacology, and Disease. It also explores topics under Gastroenterology, Type 2 diabetes, and Oncology.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited Arab Emirates

Primary LanguageEnglish

1st Year Published2006

FrequencyEight Issues A Year, 2019-

StatusActive (last: 2026)

Total Publications2,039

Publisher OrgBentham Science Publishers

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/11 · 55%

✅

Do you know the journal / publisher?

Bentham Science Publishers

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2212-3873

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

181

3.1k

2019

290

3.6k

2020

162

1.4k

2021

173

1.3k

2022

211

1.1k

2023

166

512

2024

191

204

2025

158

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Endocrinology, Diabetes and MetabolismQ3

Immunology and AllergyQ3

Subject Classification

Web of Science Categories

Endocrinology & MetabolismImmunologyPharmacology & Pharmacy

Scopus Categories

Immunology and AllergyEndocrinology, Diabetes and Metabolism

Research Topics (OpenAlex)

Thyroid Disorders and TreatmentsAdipokines, Inflammation, and Metabolic DiseasesDiabetes and associated disordersThyroid Cancer Diagnosis and TreatmentNatural Antidiabetic Agents StudiesVitamin D Research StudiesDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and ManagementPancreatic function and diabetesPituitary Gland Disorders and Treatments

Frequently asked questions about Endocrine, Metabolic and Immune Disorders - Drug Targets

Is Endocrine, Metabolic and Immune Disorders - Drug Targets a predatory journal?

PubScope has no integrity flags on record for Endocrine, Metabolic and Immune Disorders - Drug Targets: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Endocrine, Metabolic and Immune Disorders - Drug Targets?

Endocrine, Metabolic and Immune Disorders - Drug Targets is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.30.

Is Endocrine, Metabolic and Immune Disorders - Drug Targets indexed in Scopus and Web of Science?

Endocrine, Metabolic and Immune Disorders - Drug Targets is indexed in Web of Science, Scopus.